The social impacts of PFAS treatment technologies are still under-researched. All treatment technologies encompass both positive and negative social aspects. The primary social benefit is public health improvement due to PFAS removal from water sources. IX treatment effectively removes PFAS from groundwater, reducing exposure and lowering the risk of cancer and endocrine disruption. Similarly, GAC treatment significantly reduces PFAS levels in drinking water, decreasing the risk of cancer, liver damage, and thyroid disease. However, IX resin production and disposal pose social risks due to high ozone depletion potential, leading to respiratory issues, and ecological damage. Conversely, GAC emits higher levels of carcinogens and non-carcinogens compared to IX, negatively impacting air quality and human health. Previous research highlights important distinctions between different PFAS treatment technologies, particularly in terms of health and social impacts. For example, IX has generally been found to result in higher life cycle human health impacts compared to GAC. These impacts are part of the treatment process itself and do not reflect the health benefits gained from the reduction of contaminants in the treated water. This suggests that GAC may be a more favorable option in contexts where minimizing health risks is a priority. Using the social sustainability evaluation matrix, studies have demonstrated that GAC is more socially sustainable than IX. The social sustainability evaluation matrix, an Excel-based tool, enables users to specify, and quantify the social aspects of a project by identifying key indicators for measurement. Its scoring system categorizes impacts into five sections: no impacts, positive, ideal, negative, and unacceptable. This comprehensive assessment framework helps highlight the social advantages of GAC over IX, reinforcing its potential benefits beyond just environmental considerations. In the context of landfill leachate treatment, the choice between onsite and offsite technologies has significant implications for human health. Research suggests that onsite multistage membrane technology may provide greater health benefits compared to offsite scenarios; however, further studies are needed to confirm these findings. One of the main reasons could be the elimination of transportation risks and the ability to directly manage and optimize the treatment process. This leads to lower human health risks associated with PFAS exposure. This finding underscores the importance of location and technology integration in optimizing the health outcomes of treatment processes. These insights collectively emphasize the need for a holistic evaluation of PFAS treatment technologies, considering health, social, and logistical factors. By understanding these nuances, decision-makers can better select and implement technologies that align with broader sustainability goals.